Ohrid April 2013

The aims of MPN&MPNr-EuroNet’s seventh workshop to be held in Ohrid, Republic of Macedonia, on April 24-26, 2013 are:

1. to share information on the newest developments in MPN and related congenital diseases, congenital erythrocytosis and hereditary thrombocythemia;
2. to exchange and diffuse information on the molecular assays developed for diagnosis or research in laboratories working on MPN and related diseases across Europe;
3. to discuss and plan for the various tasks and objectives of the 4 working groups (WG);
4. to help and encourage young scientists to pursue a career dedicated to MPN.

To do so, abstracts will be selected for short talks in the special and working group sessions. Posters will be presented during the whole length of the meeting.

Each WG will convene under the direction of the WG chairs, first on April 24th and 25th, 2013 in plenary sessions, then in simultaneous study groups, on April 26th, 2013. New participants are encouraged to become actively involved in specific WG tasks. In addition, plenary sessions will cover the newest knowledge in MPN, with special focus on genetics, epigenetics, miRNA, Jak/Stat and hypoxia response pathways.

Participants to the seventh MPN&MPNr-EuroNet meeting will have the opportunity to hear from the best experts about the newest developments in the molecular diagnosis of MPN and related congenital diseases. They will have the opportunity to present their own work and original diagnostic assays, and exchange with colleagues on the newest genes and techniques of interest in the field of MPN, congenital erythrocytosis and hereditary thrombocythemia. By joining one of MPN&MPNr-EuroNet working groups, they will be able to contribute actively, productively and durably in innovation, optimization and standardization of the biological diagnosis of MPN and related congenital diseases in Europe.

molecular diagnosis, myeloproliferative neoplasms, congenital erythrocytosis, hereditary thrombocythemia, standardization, European network

Click on the following link to get more info about MPN&MPNr-EuroNet.

Participants are encouraged to submit an abstract in relation to the diagnosis of MPN, new mutations in MPN, the histopathology of MPN, inflammation in MPN, congenital erythrocytosis, hereditary thrombocythemia, and the JAK/STAT and other signalling pathways of interest in MPN. Early stage researchers and junior biologists and clinicians are especially encouraged to submit abstracts.
Abstracts should be composed as follows:

• Title
• Names of co-authors
• Institutions and addresses
• E-mail address of corresponding author
• Text (body of text less than 2000 characters, including spaces).

All abstracts will be put together in an Abstract Book that will be distributed to participants during the meeting.
The deadline for submission of abstracts is March 1st, 2013.

In order to submit an abstract, participants should first be registered, then, being logged in, choose Abstract in the menu bar on Registration page.

MPN&MPN-EuroNet offers scholarships to early state researchers (ESRs). ESRs are PhD students, researchers, biologists or clinicians who received their MD or PhD degree less than 8 years ago. To apply for a scholarship, ESRs must submit an abstract following the on line procedure, and send a letter of motivation and their curriculum vitae to Mrs. Elodie Hervio. Click on the following link to send a mail to Mrs. Elodie Hervio. Please upload here the CV template .
The deadline for application to a scholarship is March 1st, 2013.
Applicants will be informed of the decision regarding attribution of scholarship via E-mail by April 1st, 2013.

Reimbursements of COST members and scholarship recipients
COST Action BM 0902 Management Committee members, substitute members and scholarship recipients must register in e-COST in order to be reimbursed for their travel and lodging expanses. Click on the following link to get access to e-COST. To allow sufficient time for treating the files of all individuals applying for reimbursement, registration in e-COST should be done before March 30th, 2013.